Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
Avanos Medical, Inc., a prominent player in the health and social work services industry, is headquartered in the United States. Founded in 2014, the company has quickly established itself as a leader in innovative medical solutions, particularly in the areas of pain management and surgical care.
Avanos is renowned for its unique product offerings, including advanced wound care and drug delivery systems that enhance patient outcomes and streamline healthcare processes. With a commitment to improving patient quality of life, the company has achieved significant milestones, positioning itself as a trusted partner in the healthcare sector.
Operating across various regions, Avanos Medical continues to expand its market presence, driven by a dedication to innovation and excellence in patient care.
+10 vs industry average
Avanos Medical, Inc.’s score of 33 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Health Services has typical carbon intensity
The Health Services industry has reduced its overall emissions by 23% since 2018
Scope 3 accounts for ••• of total emissions.
Avanos Medical, Inc., headquartered in the US and operating within the Health and social work services sector, reported a total of approximately 84.0 million kg CO2e for the year 2025. This figure encompasses Scope 1, Scope 2, and Scope 3 emissions. For 2025, Scope 1 emissions were approximately 1.6 million kg CO2e, Scope 2 emissions were about 5.0 million kg CO2e, and Scope 3 emissions accounted for approximately 77.5 million kg CO2e.
In 2024, Avanos Medical, Inc. reported a total of approximately 87.6 million kg CO2e. This included about 1.5 million kg CO2e for Scope 1, approximately 12.7 million kg CO2e for Scope 2, and around 73.4 million kg CO2e for Scope 3.
For the reporting year 2024 (corresponding to 2023 emissions), the company's total emissions were approximately 14.5 million kg CO2e, comprising about 1.8 million kg CO2e in Scope 1 and approximately 12.7 million kg CO2e in Scope 2. Scope 3 data was not disclosed for this year.
Earlier data includes approximately 12.3 million kg CO2e in total emissions for 2020, with Scope 1 at about 0.2 million kg CO2e and Scope 2 at approximately 12.1 million kg CO2e. In 2019, total emissions were approximately 10.0 million kg CO2e, with Scope 1 at about 0.2 million kg CO2e and Scope 2 at around 9.8 million kg CO2e. Scope 3 emissions were not disclosed for the 2019, 2020, or 2023 reporting years.
Avanos Medical, Inc. has not publicly disclosed specific reduction targets or commitments to initiatives like the Science Based Targets initiative (SBTi) or the Climate Pledge based on the provided information.
Access structured emission data, company specific factors and auditable source documents
No climate goals have been disclosed for Avanos Medical, Inc. yet.
No scope 3 category breakdown has been disclosed yet.


You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more